These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35910792)

  • 1. Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy.
    Zhou Y; Guo Y; Chen L; Zhang X; Wu W; Yang Z; Li X; Wang Y; Hu Z; Wang Z
    Theranostics; 2022; 12(12):5488-5503. PubMed ID: 35910792
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
    Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
    Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
    PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
    Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
    Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
    J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.
    Zhu H; Leiss L; Yang N; Rygh CB; Mitra SS; Cheshier SH; Weissman IL; Huang B; Miletic H; Bjerkvig R; Enger PØ; Li X; Wang J
    Oncotarget; 2017 Feb; 8(7):12145-12157. PubMed ID: 28076333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis.
    Hu J; Xiao Q; Dong M; Guo D; Wu X; Wang B
    Front Immunol; 2020; 11():593219. PubMed ID: 33329583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulant Hydrogel-Guided Tumor Microenvironment Reprogramming to Efficiently Potentiate Macrophage-Mediated Cellular Phagocytosis for Systemic Cancer Immunotherapy.
    Liang JL; Jin XK; Luo GF; Zhang SM; Huang QX; Lin YT; Deng XC; Wang JW; Chen WH; Zhang XZ
    ACS Nano; 2023 Sep; 17(17):17217-17232. PubMed ID: 37584451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
    Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
    Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression.
    Cao X; Wang Y; Zhang W; Zhong X; Gunes EG; Dang J; Wang J; Epstein AL; Querfeld C; Sun Z; Rosen ST; Feng M
    Blood; 2022 Jun; 139(22):3290-3302. PubMed ID: 35134139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.
    Sun M; Li Y; Zhang W; Gu X; Wen R; Zhang K; Mao J; Huang C; Zhang X; Nie M; Zhang Z; Qi C; Cai K; Liu G
    Acta Biomater; 2023 Aug; 166():552-566. PubMed ID: 37236575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
    Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
    Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy.
    Zhang L; Zhang Y; Wang X; Zhou Y; Qi J; Gu L; Zhao Q; Yu R; Zhou X
    Small; 2023 Nov; 19(44):e2301439. PubMed ID: 37420326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.
    Hu J; Dong F; He Y; Xia X; Cheng F; Chen S; Hou X; Zhang P; Liu G; Li Y; Gao Q; Dong M; Li T; Li W; Xiao Q; Li X; Yu X; Xi G; Guo D; Wu X; Wang B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy.
    Fan Q; Kuang L; Wang B; Yin Y; Dong Z; Tian N; Wang J; Yin T; Wang Y
    ACS Nano; 2024 Jun; 18(22):14469-14486. PubMed ID: 38770948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of miR-340 controls pancreatic cancer cell
    Xi Q; Zhang J; Yang G; Zhang L; Chen Y; Wang C; Zhang Z; Guo X; Zhao J; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yao Z; Zhang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
    Berger G; Knelson EH; Jimenez-Macias JL; Nowicki MO; Han S; Panagioti E; Lizotte PH; Adu-Berchie K; Stafford A; Dimitrakakis N; Zhou L; Chiocca EA; Mooney DJ; Barbie DA; Lawler SE
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2111003119. PubMed ID: 35787058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 20. Engineered Bacterial Outer Membrane Vesicles as Controllable Two-Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy.
    Feng Q; Ma X; Cheng K; Liu G; Li Y; Yue Y; Liang J; Zhang L; Zhang T; Wang X; Gao X; Nie G; Zhao X
    Adv Mater; 2022 Oct; 34(40):e2206200. PubMed ID: 35985666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.